MDST Medicsight

    RNS Number : 1418U
  Medicsight Plc
  11 May 2008
   


Press Release                                                      12 May 2008









                                 Medicsight PLC



                        ("Medicsight" or "the Company")



                    First quarter summary trading statement





Medicsight PLC (AIM: MDST), industry leader in the development of Computer-Aided

Detection (CAD) and image analysis software to assist in the early detection and

diagnosis of disease, is pleased to announce its Interim Results for the first

quarter ended 31 March 2008.





Highlights





  ·      Preliminary agreement with Toshiba Medical Systems Corporation to 


         initiate global partnership



  ·      American Cancer Society (ACS) endorsed Computerised Tomography 

         Colonography ("CTC") and added CTC to its colon cancer screening 


         guidelines



 



Highlights post period end



  ·      Chinese SFDA approval



  ·      Global partnership with INFINITT, one of the world's leading medical 


         imaging and picture archiving and communication systems (PACS) 

         companies       



 



David Sumner, Chief Executive of Medicsight PLC, commented: "I am delighted with

the progress that the Company has made during the first quarter of 2008.  We

continue to bolster our contract pipeline adding Toshiba PACS division to our

list of distribution partners.  This is a significant milestone for Medicsight,

it is the start of a global partnership with Toshiba and will allow solid

penetration into the Japanese market for our MedicRead Colon workstation. This

year we received the Chinese SFDA approval and are on track to gain approvals in

Japan and the US.



"I am also pleased to say that our product delivery roadmap continues on track

and I look forward both to the launch of upgrades to existing Medicsight

software solutions and to demonstrating new clinical applications at the 2008

RSNA in November."





Summary Financial Data



For the three months to 31 March 2008



  ·      net revenue to external customers was £17,000 (31 March 2007: nil)



  ·      operating loss before interest and tax of £2,030,000 

         (31 March 2007: £1,467,000)



  ·      The group total assets position at 31 March 2008 was £24,641,000 


         (31 March 2007: £5,898,000).



 



 



                                    -ENDS-







For further information:





Medicsight plc

David Sumner                                         +44 (0)20 7605 7950

                                                     www.medicsight.com

Collins Stewart Europe Limited

Tim Mickley                                          +44 (0)20 7523 8350







Media enquiries:

Abchurch                                             Tel: +44 (0) 20 7398 7700

Heather Salmond / Stephanie Cuthbert                 Tel: +44 (0) 20 7398 7718

stephanie.cuthbert@abchurch-group.com                www.abchurch-group.com







Notes to editors



Medicsight PLC is a UK-headquartered, research driven, leading developer of

computer-aided detection (CAD) and image analysis software for the medical

imaging market. The CAD software automatically highlights suspicious areas on

computerised tomography (CT) scans of the colon and lung, helping radiologists

to identify, measure and analyse potential disease and early indicators of

disease. Medicsight's CAD software has been validated using one of the world's

Medicsight (LSE:MDST)
Historical Stock Chart
From Jun 2024 to Jul 2024

Medicsight (LSE:MDST)
Historical Stock Chart
From Jul 2023 to Jul 2024